AKST1210
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AKST1210, covering 2022-12-12 to 2023-09-29. Get the full timeline:
Most recent: Clinical Trial Update: Study to Compare Safety and Tolerability of AKST1210 Column at 2 Blood Flow Rates in Subjects With ESRD on Hemodialysis [NA]